Physician profile
Sara Workman
NPI 1750930822
$723.78
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $20.74 · 2023: $40.10 · 2024: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $111.06 | 2021-2024 | Vaxelis, Gardasil 9, Vaqta |
| Vanda Pharmaceuticals INC. | $88.34 | 2021 | |
| Novo Nordisk INC | $67.45 | 2021-2024 | Rybelsus, Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.59 | 2023-2024 | Caplyta |
| Lilly USA, LLC | $48.97 | 2024 | Zepbound, Jardiance, Mounjaro |
| Eisai INC. | $42.53 | 2021 | |
| Pfizer INC. | $37.03 | 2021 | |
| Edwards Lifesciences Corporation | $35.53 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Daiichi Sankyo INC. | $34.79 | 2021 | |
| Abbvie INC. | $25.44 | 2021 | |
| Sunovion Pharmaceuticals INC. | $25.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.68 | 2024 | Xarelto |
| Vital Connect, INC | $20.74 | 2022 | |
| Phadia US INC. | $18.73 | 2024 | Immunocap |
| Mylan Specialty L.P. | $17.87 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $17.69 | 2024 | Azstarys |
| Astellas Pharma US INC | $16.62 | 2021 | |
| Glaxosmithkline, LLC. | $14.31 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.17 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.